[350 Pages Report] According to Future Market Insights (FMI), The Global Infant Nutritional Premix Market size was estimated at USD 235 million in 2021 and expected to reach USD 370 million in 2032, at 4%.
| Attribute | Details |
|---|---|
| Market Size Value in 2022 | US$ 235 Million |
| Market Forecast Value in 2032 | US$ 370 Million |
| Global Growth Rate (2022 to 2032) | 4.0% |
| Forecast Period | 2022-2032 |
| Market Share of India in South Asia | ~25% |
Over the projection period, demand for infant nutritional premix is expected to increase significantly. The increased need for convenient and nutritious infant food has resulted from the fast migration of working women in urban areas.
Consumer awareness of the possible health benefits of infant food has prompted them to consider these items as a viable alternative to nursing. By the end of 2032, the global market is expected to have grown by about twofold, reaching a value of USD 370 million.
Premix is a mixture in which all of the essential nutrient components are blended in the proper proportions. Infants require the optimal intake of vitamins and minerals to ensure effective postnatal growth and to decrease newborn morbidity and death. As a result, to meet their nutritional needs, newborns are fed a high-nutrient food premix. Infant nutrition is a broad category that encompasses a wide range of infant nourishment items for babies and infants.
Because of the rising knowledge about the benefits of newborn nutritional premixes produced with organic ingredients, vitamins, probiotics, and amino acids, they are becoming more widely used around the world.
Increased demand for infant nutritional premixes manufactured with purified protein, growing investment by key players to develop high-quality infant nutritional premixes, and a rise in innovations in infant nutritional premixes are the factors that are expected to drive the growth of the Infant Nutritional Premix Market from 2022 to 2032
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
| Particulars | Details |
|---|---|
| H1 2021 | 4.0% |
| H1 2022 Projected | 4.0% |
| H1 2022 Expected | 4.4% |
| BPS Change | - 44 ↓ |
FMI presents a half-yearly comparison analysis and review of the market growth rates and further development prospects in the global market. The market is predominantly influenced by certain demographic and innovation factors under the subjective impact of macro and industry factors.
Some new developments that have taken place in these markets include:
The global market for Infant Nutritional Premix has witnessed H1 2021 growth at a magnitude of 4.0%. However, this growth is not evenly spread across all regions, with the developing markets recording higher growth rates of 4.4%. Thus, leaving a gap of -44 BPS points between expected and projected growth during H1 2022.
Key reasons for this change in growth rate are attributed to slow/rapid uptake of the market during the first half of the forecast period owing to improving end-user demand in key economies and their booming populations.
In particular, China and India are both seeing an increase in their consumption pattern, resulting in increased demand for the Infant Nutritional Premix market. Additionally, many other market segments are expected to perform fairly and attain promising growth prospects in the next half of the projection period.
Despite these positive prospects, there are some likely challenges that stay ahead for the industry including a shift in consumer preferences, stringent trade barriers, and a low degree of security in raw material supply, and other manufacturing inputs.
Because of the increased demand from health-conscious customers, significant firms around the world are working on advancements in medical food, particularly infant nutritional premixes.
One of the primary factors driving the growth of the Newborn Nutritional Premix Market is the increase in innovations in infant nutritional premixes with the addition of nucleotides, organic components, and probiotics.
Because of the growing knowledge of the benefits of fortified infant products, customers all over the world are increasingly turning to personalized premixes manufactured with pure protein. The leading companies throughout the world are also concentrating on producing customised mineral and vitamin premixes, which is driving the Infant Nutritional Premix Market even faster.
Over the forecast period, the United States will control over 36% of the global market, owing to the presence of important market players and a high consumption rate of baby nutritional products.
The cost of an infant automobile in the United States has risen dramatically in recent years. The average monthly cost of providing centre-based child care for an infant is USD 1,230 compared to USD 800 for a family child care home. The cost of child care for a newborn consumes 18% of a household's income on average.
Several producers have established themselves in the United States market. Similac Probiotic Tri-Blend, Similac Advance, and Similac Pro-Advance 20 are three of Abbott Nutrition's newborn premix formulations that help enhance the gut microbiome and perform as excellent breast milk substitutes.
In 2015, China's one-child policy was replaced with a two-child policy, with 17.5 million births recorded that year. This surge has had a significant impact on the baby food business, particularly on infant milk formula.
Children account for 1/3 of urban household expenditure in China, according to the National Bureau of Statistics. The majority of this money was spent on day-to-day baby feeding and meals for little children. RTD food items are becoming increasingly popular among Chinese parents since they are handy and can be tailored to their hectic schedules.
The newborn nutritional premixes market in China is being fueled by the aforementioned elements, as well as a rising desire for homemade, fresh, organic baby food. According to FMI, between 2022 and 2032, the market would increase at a CAGR of roughly 10%.
Principal Consultant
According to FMI, vitamin-based newborn nutritional premix accounted for about a third of the market share among all ingredients in 2020 and is predicted to expand at a rate of over 5% over the next decade.
The increased focus of parents on providing a nutritious meal for their children's health resulted in a demand for vitamin-based goods. To earn consumer trust, well-known brands such as Nestle-Ceregrow are meeting demand by introducing nutritious ingredients, such as essential vitamins for newborn newborns. Thickening and Binding Application is Boosting the Application Segment.
Powdered infant nutritional premixes accounted for the highest revenue share in 2021, and it is expected to continue on a favourable development trajectory with a CAGR of almost 6% over the forecast period.
The demand for powdered nutritious premixes is increasing dramatically in both developed countries and developing countries. This is due to the unique characteristics of powdered goods, such as their ease of water solubility.
The nutritional premixes market has seen a significant transition from liquid to powder form in recent years, owing to numerous benefits such as increased durability and simplicity.
Leading players are adopting novel strategies such as ground-breaking marketing tactics, the opening of new retail outlets, technical developments, and mergers and acquisitions.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Market Size Value in 2021 | US$ 235 Million |
| Market Forecast Value in 2032 | US$ 370 Million |
| Global Growth Rate | 4.0% |
| Forecast Period | 2022-2032 |
| Historical Data Available for | 2017-2021 |
| Market Analysis | MT for Volume and US$ Mn for Value |
| Key Regions Covered | North America; Latin America; Europe; Japan; APEJ and Middle East and Africa - MEA |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, EU5, Russia, Poland, China, ASEAN, Australia and New Zealand, Japan, GCC countries, North Africa, South Africa, others. |
| Key Market Segments Covered | Nature, Grade, Application, End-Use and Regions |
| Key Companies Profiled | Glanbia Plc.; Koninklijke DSM N.V; SternVitamin GmbH & Co. AG; BASF SE; Lycored Limited; Watson Inc.; Fenchem Biotek Limited; Hexagon Nutrition Pvt. Ltd.; Jubilant Life Sciences; Farbest Brands; Prinova Group LLC; Barentz International B.V; Vitablend Nederland B.V; ADM; Vaneeghan International B.V |
By Form :
By Ingredient :
By Function :
By Distribution Channel :
By Region :
The market is likely to be worth US$ 370 million by 2032.
The market CAGR through 2032 is estimated to be 4%.
The United States leads the market with 36% market share.
The growth rate of vitamin-based infant products is 5%.
Businesses are investing into retail outlets as distribution channels to extend their reach.
1. Market Overview 1.1. Market Coverage / Taxonomy 1.2. Market Definition / Scope / Limitations 2. Scenario Assessment of the Impact of COVID-19 on Infant Nutritional Premix Market 2.1. Current Scenario / Immediate Actions 2.2. Global Infant Nutritional Premix Market Forecast Scenario Comparison of Annual Growth Rates for Short Term (2022-2026) and Long Term (2027-2032) 2.3. Key Factors Impacting the Market 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Technological Advancements /Shift in technology 4. Market Background 4.1. Product Processing Methods Overview 4.2. Consumer Buying Patterns & Tendencies 4.3. Policy Developments and Regulatory Scenario 4.4. Macro-Economic Factors 4.4.1. Global GDP Growth Outlook 4.4.2. Global Industry Value Added 4.4.3. Personal Consumption Expenditures 4.4.4. Modern Trade Penetration 4.4.5. Consumer Price Indices 4.5. Forecast Factors - Relevance & Impact 4.5.1. Production/Product Processing Capacity Growth 4.5.2. Trade Tariffs and Regulation Outlook 4.5.3. Global Food and Beverage Industry Outlook 4.6. Value Chain Analysis 4.6.1. Raw Material Sourcing 4.6.2. Infant Nutritional Premix Producers 4.7. Market Dynamics 4.7.1. Drivers 4.7.2. Restraints 4.7.3. Opportunity 5. Global Infant Nutritional Premix Market Demand Analysis 2017-2021 and Forecast, 2022-2032 5.1. Historical Market Volume (MT) Analysis, 2017-2021 5.2. Current and Future Market Volume (MT) Projections, 2022-2032 5.3. Y-o-Y Growth Trend Analysis Optimistic Scenario 6. Global Infant Nutritional Premix Market - Pricing Analysis 6.1. Regional Pricing Analysis (USD/MT) By Form 6.2. Global Average Pricing Analysis Benchmark 6.3. Key factors Impacting the Pricing 7. Global Infant Nutritional Premix Market Demand (Size in USD Mn) Analysis 2017-2021 and Forecast, 2022-2032 7.1. Historical Market Value (USD Mn) Analysis, 2017-2021 7.2. Current and Future Market Value (USD Mn) Projections, 2022-2032 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis Country of Operation 8. Global Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032, By Form 8.1. Introduction / Key Findings 8.2. Historical Market Size (USD Mn) and Volume (MT) Analysis By Form, 2017-2021 8.3. Current and Future Market Size (USD Mn) and Volume (MT) Analysis and Forecast By Form 2022-2032 8.3.1. Powder 8.3.2. Liquid 8.4. Market Attractiveness Analysis by Form 9. Global Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032, By Ingredient Type 9.1. Introduction / Key Findings 9.2. Historical Market Size (USD Mn) and Volume (MT) Analysis by Ingredient Type, 2017-2021 9.3. Current and Future Market Size (USD Mn) and Volume (MT) Analysis and Forecast by Ingredient Type, 2022-2032 9.3.1. Vitamins 9.3.2. Minerals 9.3.3. Nucleotides 9.3.4. Amino Acid 9.3.5. Others 9.4. Market Attractiveness Analysis by Ingredient Type 10. Global Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032, By Function 10.1. Introduction / Key Findings 10.2. Historical Market Size (USD Mn) and Volume (MT) Analysis by Function, 2017-2021 10.3. Current and Future Market Size (USD Mn) and Volume (MT) Analysis and Forecast By Function, 2022-2032 10.3.1. Bone Health 10.3.2. Immunity 10.3.3. Digestion 10.3.4. Vision Health 10.3.5. Brain Health & Memory 10.3.6. Others 10.4. Market Attractiveness Analysis by Function 11. Global Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032, By Region 11.1. Introduction 11.2. Historical Market Size (USD Mn) and Volume (MT) Analysis By Region, 2017-2021 11.3. Current Market Size (USD Mn) and Volume (MT) Analysis and Forecast By Region, 2022-2032 11.3.1. North America 11.3.2. Latin America 11.3.3. Western Europe 11.3.4. Eastern Europe 11.3.5. APAC 11.3.6. Japan 11.3.7. Middle East and Africa 11.4. Market Attractiveness Analysis By Region 12. North America Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032 12.1. Introduction 12.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2016 - 2020 12.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2021 - 2031 12.3.1. By Country 12.3.1.1. U.S. (Market Share Analysis 2022) 12.3.1.1.1. By Form 12.3.1.1.2. By Ingredient Type 12.3.1.1.3. By Function 12.3.1.2. Canada (Market Share Analysis, 2022) 12.3.1.2.1. By Form 12.3.1.2.2. By Ingredient Type 12.3.1.2.3. By Function 12.3.2. By Form 12.3.3. By Ingredient Type 12.3.4. By Function 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Form 12.4.3. By Ingredient Type 12.4.4. By Function 12.5. Market Trends 12.6. Key Market Participants - Intensity Mapping 12.7. Drivers and Restraints - Impact Analysis 13. Latin America Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032 13.1. Introduction 13.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021 13.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032 13.3.1. By Country 13.3.1.1. Mexico (Market Share Analysis, 2022) 13.3.1.1.1. By Form 13.3.1.1.2. By Ingredient Type 13.3.1.1.3. By Function 13.3.1.2. Brazil (Market Share Analysis, 2022) 13.3.1.2.1. By Form 13.3.1.2.2. By Ingredient Type 13.3.1.2.3. By Function 13.3.1.3. Rest of LATAM (Market Share Analysis, 2022) 13.3.1.3.1. By Form 13.3.1.3.2. By Ingredient Type 13.3.1.3.3. By Function 13.3.2. By Form 13.3.3. By Ingredient Type 13.3.4. By Function 13.4. Market Attractiveness Analysis 13.4.1. By Form 13.4.2. By Ingredient Type 13.4.3. By Function 13.5. Market Trends 13.6. Key Market Participants - Intensity Mapping 13.7. Drivers and Restraints - Impact Analysis 14. Western Europe Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032 14.1. Introduction 14.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021 14.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032 14.3.1. By Country 14.3.1.1. Germany (Market Share Analysis, 2022) 14.3.1.1.1. By Form 14.3.1.1.2. By Ingredient Type 14.3.1.1.3. By Function 14.3.1.2. France (Market Share Analysis, 2022) 14.3.1.2.1. By Form 14.3.1.2.2. By Ingredient Type 14.3.1.2.3. By Function 14.3.1.3. Italy (Market Share Analysis, 2022) 14.3.1.3.1. By Form 14.3.1.3.2. By Ingredient Type 14.3.1.3.3. By Function 14.3.1.4. Spain (Market Share Analysis, 2022) 14.3.1.4.1. By Form 14.3.1.4.2. By Ingredient Type 14.3.1.4.3. By Function 14.3.1.5. U.K. (Market Share Analysis, 2022) 14.3.1.5.1. By Form 14.3.1.5.2. By Ingredient Type 14.3.1.5.3. By Function 14.3.1.6. BENELUX (Market Share Analysis, 2022) 14.3.1.6.1. By Form 14.3.1.6.2. By Ingredient Type 14.3.1.6.3. By Function 14.3.1.7. Nordic (Market Share Analysis, 2022) 14.3.1.7.1. By Form 14.3.1.7.2. By Ingredient Type 14.3.1.7.3. By Function 14.3.1.8. Rest of Western Europe (Market Share Analysis, 2022) 14.3.1.8.1. By Form 14.3.1.8.2. By Ingredient Type 14.3.1.8.3. By Function 14.3.2. By Form 14.3.3. By Ingredient Type 14.3.4. By Function 14.4. Market Attractiveness Analysis 14.4.1. By Form 14.4.2. By Ingredient Type 14.4.3. By Function 14.5. Market Trends 14.6. Key Market Participants - Intensity Mapping 14.7. Drivers and Restraints - Impact Analysis 15. Eastern Europe Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032 15.1. Introduction 15.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021 15.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032 15.3.1. By Country 15.3.1.1. Russia (Market Share Analysis, 2022) 15.3.1.1.1. By Form 15.3.1.1.2. By Ingredient Type 15.3.1.1.3. By Function 15.3.1.2. Poland (Market Share Analysis, 2022) 15.3.1.2.1. By Form 15.3.1.2.2. By Ingredient Type 15.3.1.2.3. By Function 15.3.1.3. Rest of Eastern Europe (Market Share Analysis, 2022) 15.3.1.3.1. By Form 15.3.1.3.2. By Ingredient Type 15.3.1.3.3. By Function 15.3.2. By Form 15.3.3. By Ingredient Type 15.3.4. By Function 15.4. Market Attractiveness Analysis 15.4.1. By Form 15.4.2. By Ingredient Type 15.4.3. By Function 15.5. Market Trends 15.6. Key Market Participants - Intensity Mapping 15.7. Drivers and Restraints - Impact Analysis 16. APEC Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032 16.1. Introduction 16.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021 16.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032 16.3.1. By Country 16.3.1.1. India (Market Share Analysis, 2022) 16.3.1.1.1. By Form 16.3.1.1.2. By Ingredient Type 16.3.1.1.3. By Function 16.3.1.2. Australia (Market Share Analysis, 2022) 16.3.1.2.1. By Form 16.3.1.2.2. By Ingredient Type 16.3.1.2.3. By Function 16.3.1.3. New Zealand (Market Share Analysis, 2022) 16.3.1.3.1. By Form 16.3.1.3.2. By Ingredient Type 16.3.1.3.3. By Function 16.3.1.4. ASEAN (Market Share Analysis, 2022) 16.3.1.4.1. By Form 16.3.1.4.2. By Ingredient Type 16.3.1.4.3. By Function 16.3.1.5. Rest of APAC (Market Share Analysis, 2022) 16.3.1.5.1. By Form 16.3.1.5.2. By Ingredient Type 16.3.1.5.3. By Function 16.3.2. By Form 16.3.3. By Ingredient Type 16.3.4. By Function 16.4. Market Attractiveness Analysis 16.4.1. By Form 16.4.2. By Ingredient Type 16.4.3. By Function 16.5. Market Trends 16.6. Key Market Participants - Intensity Mapping 16.7. Drivers and Restraints - Impact Analysis 17. China Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032 17.1. Introduction 17.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021 17.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032 17.3.1. By Country 17.3.2. By Form 17.3.3. By Ingredient Type 17.3.4. By Function 17.4. Market Attractiveness Analysis 17.4.1. By Form 17.4.2. By Ingredient Type 17.4.3. By Function 17.5. Market Trends 17.6. Key Market Participants - Intensity Mapping 17.7. Drivers and Restraints - Impact Analysis 18. Middle East and Africa Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032 18.1. Introduction 18.2. Historical Market Size (USD Mn) and Volume Trend Analysis By Market Taxonomy, 2017-2021 18.3. Market Size (USD Mn) and Volume Forecast By Market Taxonomy, 2022-2032 18.3.1. By Country 18.3.1.1. GCC Countries (Market Share Analysis, 2022) 18.3.1.1.1. By Form 18.3.1.1.2. By Ingredient Type 18.3.1.1.3. By Function 18.3.1.2. South Africa (Market Share Analysis, 2022) 18.3.1.2.1. By Form 18.3.1.2.2. By Ingredient Type 18.3.1.2.3. By Function 18.3.1.3. North Africa (Market Share Analysis, 2022) 18.3.1.3.1. By Form 18.3.1.3.2. By Ingredient Type 18.3.1.3.3. By Function 18.3.1.4. Rest of MEA (Market Share Analysis, 2022) 18.3.1.4.1. By Form 18.3.1.4.2. By Ingredient Type 18.3.1.4.3. By Function 18.3.2. By Form 18.3.3. By Ingredient Type 18.3.4. By Function 18.4. Market Attractiveness Analysis 18.4.1. By Form 18.4.2. By Ingredient Type 18.4.3. By Function 18.5. Market Trends 18.6. Key Market Participants - Intensity Mapping 18.7. Drivers and Restraints - Impact Analysis 19. Key Countries Infant Nutritional Premix Market Analysis 2017-2021 and Forecast 2022-2032 19.1. U.S. 19.1.1. Introduction 19.1.2. Pricing Analysis (2017, 2022, 2032) 19.1.3. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.1.3.1.1. By Form 19.1.3.1.2. By Ingredient Type 19.1.3.1.3. By Function 19.2. Canada 19.2.1. Pricing Analysis (2017, 2022, 2032) 19.2.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.2.2.1.1. By Form 19.2.2.1.2. By Ingredient Type 19.2.2.1.3. By Function 19.3. Brazil 19.3.1. Pricing Analysis (2017, 2022, 2032) 19.3.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.3.2.1.1. By Form 19.3.2.1.2. By Ingredient Type 19.3.2.1.3. By Function 19.4. Mexico 19.4.1. Pricing Analysis (2017, 2022, 2032) 19.4.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.4.2.1.1. By Form 19.4.2.1.2. By Ingredient Type 19.4.2.1.3. By Function 19.5. Germany 19.5.1. Pricing Analysis (2017, 2022, 2032) 19.5.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.5.2.1.1. By Form 19.5.2.1.2. By Ingredient Type 19.5.2.1.3. By Function 19.6. Italy 19.6.1. Pricing Analysis (2017, 2022, 2032) 19.6.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.6.2.1.1. By Form 19.6.2.1.2. By Ingredient Type 19.6.2.1.3. By Function 19.7. France 19.7.1. Pricing Analysis (2017, 2022, 2032) 19.7.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.7.2.1.1. By Form 19.7.2.1.2. By Ingredient Type 19.7.2.1.3. By Function 19.8. U.K. 19.8.1. Pricing Analysis (2017, 2022, 2032) 19.8.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.8.2.1.1. By Form 19.8.2.1.2. By Ingredient Type 19.8.2.1.3. By Function 19.9. Spain 19.9.1. Pricing Analysis (2017, 2022, 2032) 19.9.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.9.2.1.1. By Form 19.9.2.1.2. By Ingredient Type 19.9.2.1.3. By Function 19.10. Benelux 19.10.1. Pricing Analysis (2017, 2022, 2032) 19.10.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.10.2.1.1. By Form 19.10.2.1.2. By Ingredient Type 19.10.2.1.3. By Function 19.11. Russia 19.11.1. Pricing Analysis (2017, 2022, 2032) 19.11.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.11.2.1.1. By Form 19.11.2.1.2. By Ingredient Type 19.11.2.1.3. By Function 19.12. Nordic 19.12.1. Pricing Analysis (2017, 2022, 2032) 19.12.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.12.2.1.1. By Form 19.12.2.1.2. By Ingredient Type 19.12.2.1.3. By Function 19.13. Poland 19.13.1. Pricing Analysis (2017, 2022, 2032) 19.13.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.13.2.1.1. By Form 19.13.2.1.2. By Ingredient Type 19.13.2.1.3. By Function 19.14. India 19.14.1. Pricing Analysis (2017, 2022, 2032) 19.14.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.14.2.1.1. By Form 19.14.2.1.2. By Ingredient Type 19.14.2.1.3. By Function 19.15. Australia 19.15.1. Pricing Analysis (2017, 2022, 2032) 19.15.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.15.2.1.1. By Form 19.15.2.1.2. By Ingredient Type 19.15.2.1.3. By Function 19.16. New Zealand 19.16.1. Pricing Analysis (2017, 2022, 2032) 19.16.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.16.2.1.1. By Form 19.16.2.1.2. By Ingredient Type 19.16.2.1.3. By Function 19.17. ASEAN 19.17.1. Pricing Analysis (2017, 2022, 2032) 19.17.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.17.2.1.1. By Form 19.17.2.1.2. By Ingredient Type 19.17.2.1.3. By Function 19.18. China 19.18.1. Pricing Analysis (2017, 2022, 2032) 19.18.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.18.2.1.1. By Form 19.18.2.1.2. By Ingredient Type 19.18.2.1.3. By Function 19.19. GCC Countries 19.19.1. Pricing Analysis (2017, 2022, 2032) 19.19.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.19.2.1.1. By Form 19.19.2.1.2. By Ingredient Type 19.19.2.1.3. By Function 19.20. South Africa 19.20.1. Pricing Analysis (2017, 2022, 2032) 19.20.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.20.2.1.1. By Form 19.20.2.1.2. By Ingredient Type 19.20.2.1.3. By Function 19.21. North Africa 19.21.1. Pricing Analysis (2017, 2022, 2032) 19.21.2. Market Value and Volume Analysis 2017-2021 and Forecast 2022-2032 19.21.2.1.1. By Form 19.21.2.1.2. By Ingredient Type 19.21.2.1.3. By Function 20. Market Structure Analysis- Global Assessment 20.1. Company Dashboard 20.2. Industry Structure Analysis by Tier of Companies, 2021E 20.3. Company Share Analysis of Top Players, 2021E 20.3.1. Company Share By Form 20.3.2. Company Share By Region 20.4. Competition Benchmarking- Matrix 21. Competition Deep Dive (Tentative List) 21.1. Competition Deep Dive 21.1.1. Glanbia Plc 21.1.1.1. Overview 21.1.1.2. Product Portfolio 21.1.1.3. Profitability by Market Segments 21.1.1.4. Sales Footprint 21.1.1.5. Strategy Overview 21.1.1.5.1. Product Strategy 21.1.2. Royal DSM N.V 21.1.2.1. Overview 21.1.2.2. Product Portfolio 21.1.2.3. Profitability by Market Segments 21.1.2.4. Sales Footprint 21.1.2.5. Strategy Overview 21.1.2.5.1. Product Strategy 21.1.3. SternVitamin GmbH & CO. KG 21.1.3.1. Overview 21.1.3.2. Product Portfolio 21.1.3.3. Profitability by Market Segments 21.1.3.4. Sales Footprint 21.1.3.5. Strategy Overview 21.1.3.5.1. Product Strategy 21.1.3.6. BASF SE Overview 21.1.3.7. Product Portfolio 21.1.3.8. Profitability by Market Segments 21.1.3.9. Sales Footprint 21.1.3.10. Strategy Overview 21.1.3.10.1. Product Strategy 21.1.4. Lycored Limited 21.1.4.1. Overview 21.1.4.2. Product Portfolio 21.1.4.3. Profitability by Market Segments 21.1.4.4. Sales Footprint 21.1.4.5. Strategy Overview 21.1.4.5.1. Product Strategy 21.1.5. Watson-Inc. 21.1.5.1. Overview 21.1.5.2. Product Portfolio 21.1.5.3. Profitability by Market Segments 21.1.5.4. Sales Footprint 21.1.5.5. Strategy Overview 21.1.5.5.1. Product Strategy 21.1.6. Fenchem biotek Ltd 21.1.6.1. Overview 21.1.6.2. Product Portfolio 21.1.6.3. Profitability by Market Segments 21.1.6.4. Sales Footprint 21.1.6.5. Strategy Overview 21.1.6.5.1. Product Strategy 21.1.7. Hexagon Nutrition Pvt. Ltd. 21.1.7.1. Overview 21.1.7.2. Product Portfolio 21.1.7.3. Profitability by Market Segments 21.1.7.4. Sales Footprint 21.1.7.5. Strategy Overview 21.1.7.5.1. Product Strategy 21.1.8. Jubilant Life Sciences Limited 21.1.8.1. Overview 21.1.8.2. Product Portfolio 21.1.8.3. Profitability by Market Segments 21.1.8.4. Sales Footprint 21.1.8.5. Strategy Overview 21.1.8.5.1. Product Strategy 21.1.9. Archer Daniel Midlands Company 21.1.9.1. Overview 21.1.9.2. Product Portfolio 21.1.9.3. Profitability by Market Segments 21.1.9.4. Sales Footprint 21.1.9.5. Strategy Overview 21.1.9.5.1. Product Strategy 21.1.10. Farbest Brands 21.1.10.1. Overview 21.1.10.2. Product Portfolio 21.1.10.3. Profitability by Market Segments 21.1.10.4. Sales Footprint 21.1.10.5. Strategy Overview 21.1.10.5.1. Product Strategy 21.1.11. Prinova Group 21.1.11.1. Overview 21.1.11.2. Product Portfolio 21.1.11.3. Profitability by Market Segments 21.1.11.4. Sales Footprint 21.1.11.5. Strategy Overview 21.1.11.5.1. Product Strategy 21.1.12. Others on Additional Request 21.1.12.1. Overview 21.1.12.2. Product Portfolio 21.1.12.3. Profitability by Market Segments 21.1.12.4. Sales Footprint 21.1.12.5. Strategy Overview 21.1.12.5.1. Product Strategy Note: Above list is subjected to change during the course of study 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Food and Beverage Insights
View Reports
Infant Nutritional Premix Market
